Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Janux Therapeutics’ $296.5 Million Common Stock Offering
CG Oncology’s $105 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised Foresite Capital on the transaction. CG Oncology, Inc. announced the close of an oversubscribed $105 million crossover financing round, co-led...
Upstream Bio’s $200 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Venrock Healthcare Capital Partners on IP matters related to the transaction. Upstream Bio, a clinical-stage biotech company, announced the completion of...